Literature DB >> 7083636

Autoimmune thyroiditis: conversion of low-responder mice to high-responders by cyclophosphamide.

A O Vladutiu.   

Abstract

Inbred strains of mice are low- or high-responders with respect to the magnitude of thyroid infiltrates that appear after immunization with mouse thyroglobulin emulsified in Freund's complete adjuvant. This aspect of the immune response to thyroglobulin is strongly controlled by the major histocompatibility complex. Low-responder strains treated with cyclophosphamide, before the antigenic challenge, were converted to high-responders. This suggests that in low-responder mice, a specific suppressor activity influences the development of the thyroid lesions characteristic for the autoimmune thyroiditis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7083636      PMCID: PMC1536417     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Evidence for thyroglobulin-reactive T cells in good responder mice.

Authors:  P S Esquivel; Y C Kong; N R Rose
Journal:  Cell Immunol       Date:  1978-04       Impact factor: 4.868

2.  Autoimmune murine thyroiditis. V. Genetic influence on the disease in BSVS and BRVR mice.

Authors:  N R Rose; A O Vladutiu; C S David; D C Shreffler
Journal:  Clin Exp Immunol       Date:  1973-10       Impact factor: 4.330

3.  Transfer of experimental autoimmune thyroiditis of the mouse by serum.

Authors:  A O Vladutiu; N R Rose
Journal:  J Immunol       Date:  1971-04       Impact factor: 5.422

4.  Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice.

Authors:  C C Bernard
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

5.  Murine thyroiditis. 3. Influence of syngeneic and allogeneic thyroid antigen on induction of the disease.

Authors:  A O Vladutiu; N R Rose
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

6.  Reversal of experimental allergic thyroiditis in cyclophosphamide-treated rats.

Authors:  P Y Paterson; D G Drobish
Journal:  Clin Exp Immunol       Date:  1975-04       Impact factor: 4.330

7.  Transfer of experimental autoimmune thyroiditis by serum from thyroidectomized donors.

Authors:  R M Nakamura; W O Weigle
Journal:  J Exp Med       Date:  1969-08-01       Impact factor: 14.307

8.  Suppression of thyroid lesions in rabbits by treatment with cyclophosphamide after the induction of thyroiditis.

Authors:  R M Nakamura; W O Weigle
Journal:  Clin Exp Immunol       Date:  1970-10       Impact factor: 4.330

9.  Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions.

Authors:  N R Rose; F J Twarog; A J Crowle
Journal:  J Immunol       Date:  1971-03       Impact factor: 5.422

10.  Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice.

Authors:  G Cudkowicz; M Bennett
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

View more
  4 in total

1.  Occurrence of lymphocyte proliferative response to thyroglobulin and antithyroglobulin antibodies in normal individuals: lack of correlation with HLA.

Authors:  M Bagnasco; A Orlandini; G Melioli; D Venuti; G W Canonica; G B Ferrara
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

2.  Characterization of a thyroiditis-inducing thyroglobulin-specific T-cell clone restricted by the H-2 molecule of a low responder mouse strain.

Authors:  Y Hiyama; Y Kohno; A Hoshioka; N Shimojo; O Tarutani; T Yokochi; N Maruyama; H Niimi
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

3.  Experimental autoimmune thyroiditis: modulation of the disease level in high and low responder mice by thymosin.

Authors:  V Tomazic; C M Suter; P B Chretien
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

4.  Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci.

Authors:  W C Watson; A S Townes
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.